Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era

The importance of completeness of revascularization by percutaneous coronary intervention in patients with multivessel disease is unclear in that there is little information on the impact of incomplete revascularization outside of randomized trials. The objective of this study is to compare long-ter...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Circulation (New York, N.Y.) N.Y.), 2006-05, Vol.113 (20), p.2406-2412
Hauptverfasser: HANNAN, Edward L, RACZ, Michael, HOLMES, David R, KING, Spencer B, WALFORD, Gary, AMBROSE, John A, SHARMA, Samin, KATZ, Stanley, CLARK, Luther T, JONES, Robert H
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2412
container_issue 20
container_start_page 2406
container_title Circulation (New York, N.Y.)
container_volume 113
creator HANNAN, Edward L
RACZ, Michael
HOLMES, David R
KING, Spencer B
WALFORD, Gary
AMBROSE, John A
SHARMA, Samin
KATZ, Stanley
CLARK, Luther T
JONES, Robert H
description The importance of completeness of revascularization by percutaneous coronary intervention in patients with multivessel disease is unclear in that there is little information on the impact of incomplete revascularization outside of randomized trials. The objective of this study is to compare long-term mortality and subsequent revascularization for percutaneous coronary intervention patients receiving stents who were completely revascularized (CR) with those who were incompletely revascularized (IR). Patients from New York State's Percutaneous Coronary Interventions Reporting System were subdivided into patients who were CR and IR. Then subsets of IR patients were contrasted with CR patients. Differences in long-term survival and subsequent revascularization for CR and IR patients were compared after adjustment for differences in preprocedural risk. A total of 68.9% of all stent patients with multivessel disease who were studied were IR, and 30.1% of all patients had total occlusions and/or > or =2 IR vessels. At baseline, the following patients were at higher risk: those who were older and those with more comorbid conditions, worse ejection fraction, and more renal disease and stroke. After adjustment for these baseline differences, IR patients were significantly more likely to die at any time (adjusted hazard ratio=1.15; 95% confidence interval, 1.01 to 1.30) than CR patients. IR patients with total occlusions and a total of > or =2 IR vessels were at the highest risk compared with CR patients (hazard ratio=1.36; 95% confidence interval, 1.12 to 1.66). IR with stenting is associated with an adverse impact on long-term mortality, and consideration should be given to either achieving CR, opting for surgery, or monitoring percutaneous coronary intervention patients with IR more closely after discharge.
doi_str_mv 10.1161/CIRCULATIONAHA.106.612267
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67987496</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67987496</sourcerecordid><originalsourceid>FETCH-LOGICAL-c505t-eb1e145f045a05a7ee79f986ac01eae588df51d026da8a96c732759a4a9d19f83</originalsourceid><addsrcrecordid>eNpVkN1LwzAUxYMoOj_-BakP-taZtE3SPJbix2A4kO253KW3WmmbmqSC_vVGNxAhEO7N75xwDiFXjM4ZE-y2XDyXm2WxXqyeisdizqiYC5YkQh6QGeNJFmc8VYdkRilVsUyT5IScOvcWRpFKfkxOmJA0yYSakWnRj6B9ZJpIm37s0OOAzv3MI1o9eRjQTC48WjOA_YzawaP9wMG3ZogsfoDTUwe2_YLfTTidGV7iAPWRmXwwRRdEkX_FyAVzH6GFc3LUQOfwYn-fkc393bp8jJerh0VZLGPNKfcxbhmyjDc040A5SESpGpUL0JQhIM_zuuGspomoIQcldMgquYIMVM1Uk6dn5GbnO1rzPqHzVd86jV23S1UJqXKZKRFAtQO1Nc5ZbKrRtn3IWzFa_XRe_e88rEW16zxoL_efTNse6z_lvuQAXO-BUBZ0jYVBt-6Pk3ka4qr0G_Y7jzg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67987496</pqid></control><display><type>article</type><title>Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era</title><source>Journals@Ovid Complete - AutoHoldings</source><source>MEDLINE</source><source>American Heart Association Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>HANNAN, Edward L ; RACZ, Michael ; HOLMES, David R ; KING, Spencer B ; WALFORD, Gary ; AMBROSE, John A ; SHARMA, Samin ; KATZ, Stanley ; CLARK, Luther T ; JONES, Robert H</creator><creatorcontrib>HANNAN, Edward L ; RACZ, Michael ; HOLMES, David R ; KING, Spencer B ; WALFORD, Gary ; AMBROSE, John A ; SHARMA, Samin ; KATZ, Stanley ; CLARK, Luther T ; JONES, Robert H</creatorcontrib><description>The importance of completeness of revascularization by percutaneous coronary intervention in patients with multivessel disease is unclear in that there is little information on the impact of incomplete revascularization outside of randomized trials. The objective of this study is to compare long-term mortality and subsequent revascularization for percutaneous coronary intervention patients receiving stents who were completely revascularized (CR) with those who were incompletely revascularized (IR). Patients from New York State's Percutaneous Coronary Interventions Reporting System were subdivided into patients who were CR and IR. Then subsets of IR patients were contrasted with CR patients. Differences in long-term survival and subsequent revascularization for CR and IR patients were compared after adjustment for differences in preprocedural risk. A total of 68.9% of all stent patients with multivessel disease who were studied were IR, and 30.1% of all patients had total occlusions and/or &gt; or =2 IR vessels. At baseline, the following patients were at higher risk: those who were older and those with more comorbid conditions, worse ejection fraction, and more renal disease and stroke. After adjustment for these baseline differences, IR patients were significantly more likely to die at any time (adjusted hazard ratio=1.15; 95% confidence interval, 1.01 to 1.30) than CR patients. IR patients with total occlusions and a total of &gt; or =2 IR vessels were at the highest risk compared with CR patients (hazard ratio=1.36; 95% confidence interval, 1.12 to 1.66). IR with stenting is associated with an adverse impact on long-term mortality, and consideration should be given to either achieving CR, opting for surgery, or monitoring percutaneous coronary intervention patients with IR more closely after discharge.</description><identifier>ISSN: 0009-7322</identifier><identifier>EISSN: 1524-4539</identifier><identifier>DOI: 10.1161/CIRCULATIONAHA.106.612267</identifier><identifier>PMID: 16702469</identifier><identifier>CODEN: CIRCAZ</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams &amp; Wilkins</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Angioplasty, Balloon, Coronary ; Biological and medical sciences ; Blood and lymphatic vessels ; Cardiology. Vascular system ; Clinical Trials as Topic ; Coronary Disease - mortality ; Coronary Disease - surgery ; Coronary heart disease ; Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous ; Female ; Heart ; Humans ; Male ; Medical sciences ; Middle Aged ; Myocardial Infarction - mortality ; Myocardial Infarction - surgery ; Myocardial Revascularization - adverse effects ; Myocardial Revascularization - mortality ; Myocardial Revascularization - standards ; New York - epidemiology ; Recurrence ; Retrospective Studies ; Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis ; Stents - adverse effects ; Stroke Volume ; Survival Rate ; Treatment Outcome</subject><ispartof>Circulation (New York, N.Y.), 2006-05, Vol.113 (20), p.2406-2412</ispartof><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c505t-eb1e145f045a05a7ee79f986ac01eae588df51d026da8a96c732759a4a9d19f83</citedby><cites>FETCH-LOGICAL-c505t-eb1e145f045a05a7ee79f986ac01eae588df51d026da8a96c732759a4a9d19f83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,3674,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17835059$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16702469$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>HANNAN, Edward L</creatorcontrib><creatorcontrib>RACZ, Michael</creatorcontrib><creatorcontrib>HOLMES, David R</creatorcontrib><creatorcontrib>KING, Spencer B</creatorcontrib><creatorcontrib>WALFORD, Gary</creatorcontrib><creatorcontrib>AMBROSE, John A</creatorcontrib><creatorcontrib>SHARMA, Samin</creatorcontrib><creatorcontrib>KATZ, Stanley</creatorcontrib><creatorcontrib>CLARK, Luther T</creatorcontrib><creatorcontrib>JONES, Robert H</creatorcontrib><title>Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era</title><title>Circulation (New York, N.Y.)</title><addtitle>Circulation</addtitle><description>The importance of completeness of revascularization by percutaneous coronary intervention in patients with multivessel disease is unclear in that there is little information on the impact of incomplete revascularization outside of randomized trials. The objective of this study is to compare long-term mortality and subsequent revascularization for percutaneous coronary intervention patients receiving stents who were completely revascularized (CR) with those who were incompletely revascularized (IR). Patients from New York State's Percutaneous Coronary Interventions Reporting System were subdivided into patients who were CR and IR. Then subsets of IR patients were contrasted with CR patients. Differences in long-term survival and subsequent revascularization for CR and IR patients were compared after adjustment for differences in preprocedural risk. A total of 68.9% of all stent patients with multivessel disease who were studied were IR, and 30.1% of all patients had total occlusions and/or &gt; or =2 IR vessels. At baseline, the following patients were at higher risk: those who were older and those with more comorbid conditions, worse ejection fraction, and more renal disease and stroke. After adjustment for these baseline differences, IR patients were significantly more likely to die at any time (adjusted hazard ratio=1.15; 95% confidence interval, 1.01 to 1.30) than CR patients. IR patients with total occlusions and a total of &gt; or =2 IR vessels were at the highest risk compared with CR patients (hazard ratio=1.36; 95% confidence interval, 1.12 to 1.66). IR with stenting is associated with an adverse impact on long-term mortality, and consideration should be given to either achieving CR, opting for surgery, or monitoring percutaneous coronary intervention patients with IR more closely after discharge.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Angioplasty, Balloon, Coronary</subject><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>Cardiology. Vascular system</subject><subject>Clinical Trials as Topic</subject><subject>Coronary Disease - mortality</subject><subject>Coronary Disease - surgery</subject><subject>Coronary heart disease</subject><subject>Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous</subject><subject>Female</subject><subject>Heart</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Myocardial Infarction - mortality</subject><subject>Myocardial Infarction - surgery</subject><subject>Myocardial Revascularization - adverse effects</subject><subject>Myocardial Revascularization - mortality</subject><subject>Myocardial Revascularization - standards</subject><subject>New York - epidemiology</subject><subject>Recurrence</subject><subject>Retrospective Studies</subject><subject>Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis</subject><subject>Stents - adverse effects</subject><subject>Stroke Volume</subject><subject>Survival Rate</subject><subject>Treatment Outcome</subject><issn>0009-7322</issn><issn>1524-4539</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkN1LwzAUxYMoOj_-BakP-taZtE3SPJbix2A4kO253KW3WmmbmqSC_vVGNxAhEO7N75xwDiFXjM4ZE-y2XDyXm2WxXqyeisdizqiYC5YkQh6QGeNJFmc8VYdkRilVsUyT5IScOvcWRpFKfkxOmJA0yYSakWnRj6B9ZJpIm37s0OOAzv3MI1o9eRjQTC48WjOA_YzawaP9wMG3ZogsfoDTUwe2_YLfTTidGV7iAPWRmXwwRRdEkX_FyAVzH6GFc3LUQOfwYn-fkc393bp8jJerh0VZLGPNKfcxbhmyjDc040A5SESpGpUL0JQhIM_zuuGspomoIQcldMgquYIMVM1Uk6dn5GbnO1rzPqHzVd86jV23S1UJqXKZKRFAtQO1Nc5ZbKrRtn3IWzFa_XRe_e88rEW16zxoL_efTNse6z_lvuQAXO-BUBZ0jYVBt-6Pk3ka4qr0G_Y7jzg</recordid><startdate>20060523</startdate><enddate>20060523</enddate><creator>HANNAN, Edward L</creator><creator>RACZ, Michael</creator><creator>HOLMES, David R</creator><creator>KING, Spencer B</creator><creator>WALFORD, Gary</creator><creator>AMBROSE, John A</creator><creator>SHARMA, Samin</creator><creator>KATZ, Stanley</creator><creator>CLARK, Luther T</creator><creator>JONES, Robert H</creator><general>Lippincott Williams &amp; Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20060523</creationdate><title>Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era</title><author>HANNAN, Edward L ; RACZ, Michael ; HOLMES, David R ; KING, Spencer B ; WALFORD, Gary ; AMBROSE, John A ; SHARMA, Samin ; KATZ, Stanley ; CLARK, Luther T ; JONES, Robert H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c505t-eb1e145f045a05a7ee79f986ac01eae588df51d026da8a96c732759a4a9d19f83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Angioplasty, Balloon, Coronary</topic><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>Cardiology. Vascular system</topic><topic>Clinical Trials as Topic</topic><topic>Coronary Disease - mortality</topic><topic>Coronary Disease - surgery</topic><topic>Coronary heart disease</topic><topic>Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous</topic><topic>Female</topic><topic>Heart</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Myocardial Infarction - mortality</topic><topic>Myocardial Infarction - surgery</topic><topic>Myocardial Revascularization - adverse effects</topic><topic>Myocardial Revascularization - mortality</topic><topic>Myocardial Revascularization - standards</topic><topic>New York - epidemiology</topic><topic>Recurrence</topic><topic>Retrospective Studies</topic><topic>Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis</topic><topic>Stents - adverse effects</topic><topic>Stroke Volume</topic><topic>Survival Rate</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>HANNAN, Edward L</creatorcontrib><creatorcontrib>RACZ, Michael</creatorcontrib><creatorcontrib>HOLMES, David R</creatorcontrib><creatorcontrib>KING, Spencer B</creatorcontrib><creatorcontrib>WALFORD, Gary</creatorcontrib><creatorcontrib>AMBROSE, John A</creatorcontrib><creatorcontrib>SHARMA, Samin</creatorcontrib><creatorcontrib>KATZ, Stanley</creatorcontrib><creatorcontrib>CLARK, Luther T</creatorcontrib><creatorcontrib>JONES, Robert H</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Circulation (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>HANNAN, Edward L</au><au>RACZ, Michael</au><au>HOLMES, David R</au><au>KING, Spencer B</au><au>WALFORD, Gary</au><au>AMBROSE, John A</au><au>SHARMA, Samin</au><au>KATZ, Stanley</au><au>CLARK, Luther T</au><au>JONES, Robert H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era</atitle><jtitle>Circulation (New York, N.Y.)</jtitle><addtitle>Circulation</addtitle><date>2006-05-23</date><risdate>2006</risdate><volume>113</volume><issue>20</issue><spage>2406</spage><epage>2412</epage><pages>2406-2412</pages><issn>0009-7322</issn><eissn>1524-4539</eissn><coden>CIRCAZ</coden><abstract>The importance of completeness of revascularization by percutaneous coronary intervention in patients with multivessel disease is unclear in that there is little information on the impact of incomplete revascularization outside of randomized trials. The objective of this study is to compare long-term mortality and subsequent revascularization for percutaneous coronary intervention patients receiving stents who were completely revascularized (CR) with those who were incompletely revascularized (IR). Patients from New York State's Percutaneous Coronary Interventions Reporting System were subdivided into patients who were CR and IR. Then subsets of IR patients were contrasted with CR patients. Differences in long-term survival and subsequent revascularization for CR and IR patients were compared after adjustment for differences in preprocedural risk. A total of 68.9% of all stent patients with multivessel disease who were studied were IR, and 30.1% of all patients had total occlusions and/or &gt; or =2 IR vessels. At baseline, the following patients were at higher risk: those who were older and those with more comorbid conditions, worse ejection fraction, and more renal disease and stroke. After adjustment for these baseline differences, IR patients were significantly more likely to die at any time (adjusted hazard ratio=1.15; 95% confidence interval, 1.01 to 1.30) than CR patients. IR patients with total occlusions and a total of &gt; or =2 IR vessels were at the highest risk compared with CR patients (hazard ratio=1.36; 95% confidence interval, 1.12 to 1.66). IR with stenting is associated with an adverse impact on long-term mortality, and consideration should be given to either achieving CR, opting for surgery, or monitoring percutaneous coronary intervention patients with IR more closely after discharge.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams &amp; Wilkins</pub><pmid>16702469</pmid><doi>10.1161/CIRCULATIONAHA.106.612267</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0009-7322
ispartof Circulation (New York, N.Y.), 2006-05, Vol.113 (20), p.2406-2412
issn 0009-7322
1524-4539
language eng
recordid cdi_proquest_miscellaneous_67987496
source Journals@Ovid Complete - AutoHoldings; MEDLINE; American Heart Association Journals; EZB-FREE-00999 freely available EZB journals
subjects Adult
Aged
Aged, 80 and over
Angioplasty, Balloon, Coronary
Biological and medical sciences
Blood and lymphatic vessels
Cardiology. Vascular system
Clinical Trials as Topic
Coronary Disease - mortality
Coronary Disease - surgery
Coronary heart disease
Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous
Female
Heart
Humans
Male
Medical sciences
Middle Aged
Myocardial Infarction - mortality
Myocardial Infarction - surgery
Myocardial Revascularization - adverse effects
Myocardial Revascularization - mortality
Myocardial Revascularization - standards
New York - epidemiology
Recurrence
Retrospective Studies
Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis
Stents - adverse effects
Stroke Volume
Survival Rate
Treatment Outcome
title Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T05%3A34%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20completeness%20of%20percutaneous%20coronary%20intervention%20revascularization%20on%20long-term%20outcomes%20in%20the%20stent%20era&rft.jtitle=Circulation%20(New%20York,%20N.Y.)&rft.au=HANNAN,%20Edward%20L&rft.date=2006-05-23&rft.volume=113&rft.issue=20&rft.spage=2406&rft.epage=2412&rft.pages=2406-2412&rft.issn=0009-7322&rft.eissn=1524-4539&rft.coden=CIRCAZ&rft_id=info:doi/10.1161/CIRCULATIONAHA.106.612267&rft_dat=%3Cproquest_cross%3E67987496%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67987496&rft_id=info:pmid/16702469&rfr_iscdi=true